Founded in 1963, Dermal was established to research, develop and market dermatological products, primarily intended for prescription. The Company's expertise focuses on the formulation of pharmaceutical preparations to treat or to be applied to the skin, paying particular attention to therapeutic bio-availability and patient acceptability.
Dermal's products are well known amongst dermatologists, general practitioners and nurses and are widely prescribed for the treatment of a variety of skin disorders, such as psoriasis, eczema, dry skin conditions and acne, as well as other conditions which can be treated by applied medication.
Further information about our medicines is available on our website www.dermal.co.uk
Stiefel, a GSK company, is committed to advancing dermatology and skin science around the world in order to help people achieve healthy, beautiful skin. Stiefel’s dedication and drive for innovation, along with its sole focus on dermatology, has established Stiefel as the world leader in the skin health industry. To learn more about Stiefel, visit www.stiefel.com.
Meda is one of the top 50 pharmaceutical companies in the world. We've offices in over 50 countries, and products in more than 120 countries across the globe.
As part of the successful Meda group, Meda UK has experienced remarkable growth of 300% in just 6 years - a trend we're set to continue. Our unique business model - which combines medically motivated product acquisitions and long-term partnerships with enhanced skills in sales and marketing - is a key factor of our success.